Fapon Biotech Delivers Antigen Diagnostic Solutions to Help Control Monkeypox Outbreak in Africa
SHENZHEN, China, Aug. 18, 2024 /PRNewswire/ — Fapon Biotech is a global leader in the In-vitro Diagnostics (IVD) industry, with a steadfast commitment to advancing global health by providing innovative diagnostic solutions. As the World Health Organization (WHO) declared monkeypox outbreak as
Viomi Technology Co., Ltd Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
GUANGZHOU, China, Aug. 17, 2024 /PRNewswire/ — Viomi Technology Co., Ltd (“Viomi” or the “Company”) (NASDAQ: VIOT), a leading technology company for home water solutions in China, today announced that it has received a written notification letter (the “Compliance
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CVS Health Corporation of Class Action Lawsuit and Upcoming Deadlines – CVS
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against CVS Health Corporation (“CVS” or the “Company”) (NYSE: CVS) and certain officers. The class action, filed in the United States District Court for the Sout
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Toyota Motor Corporation – TM
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Toyota Motor Corporation (“Toyota” or the “Company”) (NYSE: TM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Moderna, Inc. of Class Action Lawsuit and Upcoming Deadlines – MRNA
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Moderna, Inc. (“Moderna” or the “Company”) (NASDAQ: MRNA) and certain officers. The class action, filed in the United States District Court for the District
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against UiPath, Inc. – PATH
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against UiPath, Inc. (“UiPath” or the “Company”) (NYSE: PATH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BOLT
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Bolt Biotherapeutics, Inc. (“Bolt” or the “Company”) (NASDAQ: BOLT) and certain officers. The class action, filed in the United States District Court for th
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against American Airlines Group Inc. – AAL
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against American Airlines Group Inc. (“American Airlines” or the “Company”) (NASDAQ: AAL). Such investors are advised to contact Danielle Peyton at newaction@poml
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Nike, Inc. – NKE
NEW YORK, Aug. 17, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Nike, Inc. (“Nike” or the “Company”) (NYSE: NKE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.
